CTIC
Price:
$9.095
Market Cap:
$1.20B
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Industry
Biotechnology
IPO Date
1997-03-21
Stock Exchange
NASDAQ
Ticker
CTIC
According to CTI BioPharma Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 1.23. This represents a change of -47.61% compared to the average of 2.34 of the last 4 quarters.
The mean historical Current Ratio of CTI BioPharma Corp. over the last ten years is 2.28. The current 1.23 Current Ratio has changed 5.26% with respect to the historical average. Over the past ten years (40 quarters), CTIC's Current Ratio was at its highest in in the March 2020 quarter at 5.74. The Current Ratio was at its lowest in in the March 2017 quarter at 0.88.
Average
2.28
Median
2.07
Minimum
1.03
Maximum
4.01
Discovering the peaks and valleys of CTI BioPharma Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.41%
Maximum Annual Current Ratio = 4.01
Minimum Annual Increase = -67.82%
Minimum Annual Current Ratio = 1.03
| Year | Current Ratio | Change |
|---|---|---|
| 2022 | 1.23 | 19.41% |
| 2021 | 1.03 | -67.82% |
| 2020 | 3.19 | 65.68% |
| 2019 | 1.92 | -46.21% |
| 2018 | 3.58 | 46.85% |
| 2017 | 2.44 | 77.41% |
| 2016 | 1.37 | -26.32% |
| 2015 | 1.86 | -15.86% |
| 2014 | 2.22 | -44.78% |
| 2013 | 4.01 | 50.78% |
The current Current Ratio of CTI BioPharma Corp. (CTIC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.81
5-year avg
2.19
10-year avg
2.28
CTI BioPharma Corp.’s Current Ratio is less than CinCor Pharma, Inc. (8.53), less than EQRx, Inc. (27.51), less than VectivBio Holding AG (9.14), less than Ethzilla Corp. (6.19), less than POINT Biopharma Global Inc. (6.66), less than Gracell Biotechnologies Inc. (6.78), less than Poseida Therapeutics, Inc. (3.18), less than Verve Therapeutics, Inc. (9.84), less than Crescent Biopharma, Inc. (13.78),
| Company | Current Ratio | Market cap |
|---|---|---|
| 8.53 | $1.27B | |
| 27.51 | $1.14B | |
| 9.14 | $1.06B | |
| 6.19 | $56.39M | |
| 6.66 | $1.33B | |
| 6.78 | $197.97M | |
| 3.18 | $925.93M | |
| 9.84 | $994.04M | |
| 13.78 | $487.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CTI BioPharma Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CTI BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CTI BioPharma Corp.'s Current Ratio?
How is the Current Ratio calculated for CTI BioPharma Corp. (CTIC)?
What is the highest Current Ratio for CTI BioPharma Corp. (CTIC)?
What is the 3-year average Current Ratio for CTI BioPharma Corp. (CTIC)?
What is the 5-year average Current Ratio for CTI BioPharma Corp. (CTIC)?
How does the current Current Ratio for CTI BioPharma Corp. (CTIC) compare to its historical average?